Soluble TREM-1 ameliorates gouty arthritis by selective inhibition of proinflammatory cytokines and chemokines without affecting TGFβ production.
Authors:
- 9 October 2024
- journal article
- Published by Clinical and Experimental Rheumatology in Clinical and Experimental Rheumatology